Atlas Trials

Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum

Clinical trial NCT01705158 · COMPLETED

Trial details

NCT number
NCT01705158
Sponsor
ARCAGY/ GINECO GROUP
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2012-10-01
Primary completion
2014-10-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.